Artigo Acesso aberto Revisado por pares

Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies

2020; Elsevier BV; Volume: 17; Issue: 1 Linguagem: Inglês

10.1016/j.sapharm.2020.05.017

ISSN

1934-8150

Autores

Hisham A. Badreldin, Bassam Atallah,

Tópico(s)

Pharmaceutical Practices and Patient Outcomes

Resumo

Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.

Referência(s)